Tumor stem cells from glioblastoma multiforme
Glioblastoma multiforme, a World Health Organization grade IV malignant glioma, is the most common and lethal primary brain tumor with the median survival of approximately 15–25 months after treatment. Glioblastoma multiforme has been shown to be resistant to radiotherapy and chemotherapy and invari...
Main Authors: | Z. N. Nikiforova, I. A. Kudryavtsev, N. E. Arnotskaya, I. S. Bryukhovetskiy, V. E. Shevchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2016-06-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/59 |
Similar Items
-
Wnt-signaling pathway in pathogenesis of glioblastoma multiforme
by: Yu. D. Vasilets, et al.
Published: (2019-01-01) -
Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
by: Zh. D. Kobalava, et al.
Published: (2021-10-01) -
MULTIFACTORIAL PATHOGENESIS OF OSTEOPOROSIS AND THE ROLE OF GENES OF CANONICAL WNT-SIGNALING PATHWAY
by: E A Mailyan
Published: (2015-12-01) -
Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer
by: Z. A.-G. Radzhabova, et al.
Published: (2020-02-01) -
Влияние воспаления на течение асептического некроза головки бедренной кости в эксперименте.
by: Nikita Andreevich Shabaldin, et al.
Published: (2019-08-01)